Showing results (11-20 of 525) with videos related to
Sort By:
Pageof 53
Journal of Clinical Pharmacology|April 12, 2019
Population Pharmacokinetics of Pemetrexed in Adult Non-Small Cell Lung Cancer in Indian PatientsMeenakshi Srinivasan, Ayyappa Chaturvedula, Michael J Fossler, et al.Expert Review of Pharmacoeconomics & Outcomes Research|February 7, 2022
Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse eventsKit N Simpson, Michael J Fossler, Linda Wase, et al.The AAPS Journal|May 29, 2012
Population pharmacokinetics and pharmacodynamics of ribavirin in patients with chronic hepatitis C genotype 1 infectionRunyan Jin, Michael J Fossler, John G McHutchison, et al.The AAPS Journal|July 7, 2007
Population pharmacokinetics of S(-)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemateAhmed A Othman, David M Tenero, Duane A Boyle, et al.Clinical Pharmacology in Drug Development|September 4, 2021
Two-Part Phase 1 Multiple-Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of TRV734 in Healthy AdultsKimberly A Ramos, Ian E James, Franck Skobieranda, et al.Clinical Drug Investigation|March 12, 2014
Pharmacokinetic bioequivalence studies of a fixed-dose combination of tamsulosin and dutasteride in healthy volunteersMichael J Fossler, David A Collins, Meg M Thompson, et al.Clinical Pharmacology in Drug Development|July 10, 2019
A First-in-Human Clinical Study With TRV734, an Orally Bioavailable G-Protein-Biased Ligand at the μ-Opioid ReceptorIan E James, Franck Skobieranda, David G Soergel, et al.Frontiers in Pharmacology|July 30, 2019
Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling ApproachSurulivelrajan Mallayasamy, Ayyappa Chaturvedula, Michael J Fossler, et al.Clinical Pharmacology in Drug Development|November 8, 2019
The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of OliceridineAnne N Nafziger, Kelly A Arscott, Kristina Cochrane, et al.Journal of Drug Assessment|August 19, 2016
Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteersMichael J Fossler, David A Collins, Hiroko Ino, et al.Pageof 53